Bayabao, Alaizah D.
HRN: 21-95-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/19/2022
10/23/2022
PO
3.5ml
Tid
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes